Trial intelligence / Profile preview

Transdermal Clonidine in Severe Hyperemesis Gravidarum

NCT01559012Phase 3Completed

Sponsor
AOU Città della Salute e della Scienza di Torino
Start
Feb 2012
Primary completion
Dec 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of clonidine in hyperemesis gravidarum (HG), sponsored by AOU Città della Salute e della Scienza di Torino. Started Feb 2012; status: completed.

02

Drugs

clonidine
03

Conditions

hyperemesis gravidarum (HG)

Beyond the preview

Go deeper on NCT01559012.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01559012.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call